Dr. McCulla Slams FDA for Approving Dangerous mRNA Flu Vaccine

Dr. Peter McCulla criticizes the FDA's approval of Moderna's mRNA influenza vaccine, citing a 75.3% adverse reaction rate and significantly higher costs compared to traditional vaccines. He argues that the approval reflects a corrupt system prioritizing profit over public health.

AI-generated summary — may contain errors. How it works